mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.12 |
0.005 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.005 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.005 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.006 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |